FDA Finalizes Labeling Rule As Pre-emption Battle At Supreme Court Looms
This article was originally published in The Pink Sheet Daily
Executive Summary
January’s proposed rule remains mostly unchanged, but the definition of “newly acquired information” is slightly broader now.